Xenetic Biosciences XBIO Stock
Xenetic Biosciences Price Chart
Xenetic Biosciences XBIO Financial and Trading Overview
| Xenetic Biosciences stock price | 2.9 USD |
| Previous Close | 2.8 USD |
| Open | 2.76 USD |
| Bid | 2.09 USD x 200 |
| Ask | 3.67 USD x 200 |
| Day's Range | 2.76 - 2.94 USD |
| 52 Week Range | 1.9 - 13.93 USD |
| Volume | 9.72K USD |
| Avg. Volume | 15.74K USD |
| Market Cap | 6.74M USD |
| Beta (5Y Monthly) | 2.195 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.19 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
XBIO Valuation Measures
| Enterprise Value | -610096 USD |
| Trailing P/E | N/A |
| Forward P/E | -4.4545455 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.111458 |
| Price/Book (mrq) | 0.9110629 |
| Enterprise Value/Revenue | -0.191 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Xenetic Biosciences Stock Price History
| Beta (5Y Monthly) | 2.195 |
| 52-Week Change | -6.51% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 13.93 USD |
| 52 Week Low | 1.9 USD |
| 50-Day Moving Average | 3.12 USD |
| 200-Day Moving Average | 2.95 USD |
XBIO Share Statistics
| Avg. Volume (3 month) | 15.74K USD |
| Avg. Daily Volume (10-Days) | 17.77K USD |
| Shares Outstanding | 2.29M |
| Float | 1.82M |
| Short Ratio | 1.46 |
| % Held by Insiders | 15.77% |
| % Held by Institutions | 7.38% |
| Shares Short | 16.39K |
| Short % of Float | 0.73% |
| Short % of Shares Outstanding | 0.72% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -70.032% |
| Operating Margin (ttm) | -62.22% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.84% |
| Return on Equity (ttm) | -37.0069% |
Income Statement
| Revenue (ttm) | 3.19M USD |
| Revenue Per Share (ttm) | 1.69 USD |
| Quarterly Revenue Growth (yoy) | 36.00% |
| Gross Profit (ttm) | 3.19M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -2234101 USD |
| Diluted EPS (ttm) | -1.19 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.35M USD |
| Total Cash Per Share (mrq) | 3.21 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.926 |
| Book Value Per Share (mrq) | 3.227 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1821136 USD |
| Levered Free Cash Flow (ttm) | -1083466 USD |
Profile of Xenetic Biosciences
| Country | United States |
| State | MA |
| City | Framingham |
| Address | 945 Concord Street |
| ZIP | 01701 |
| Phone | 781 778 7720 |
| Website | https://www.xeneticbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors; and ErepoXen, which uses PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients. It has a sublicensing agreement with Takeda Pharmaceutical Co. Ltd, as well as various research, development, license and supply agreements with Serum Institute of India, PJSC Pharmsynthez, and SynBio, LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Q&A For Xenetic Biosciences Stock
What is a current XBIO stock price?
Xenetic Biosciences XBIO stock price today per share is 2.9 USD.
How to purchase Xenetic Biosciences stock?
You can buy XBIO shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xenetic Biosciences?
The stock symbol or ticker of Xenetic Biosciences is XBIO.
Which industry does the Xenetic Biosciences company belong to?
The Xenetic Biosciences industry is Biotechnology.
How many shares does Xenetic Biosciences have in circulation?
The max supply of Xenetic Biosciences shares is 2.29M.
What is Xenetic Biosciences Price to Earnings Ratio (PE Ratio)?
Xenetic Biosciences PE Ratio is now.
What was Xenetic Biosciences earnings per share over the trailing 12 months (TTM)?
Xenetic Biosciences EPS is -1.19 USD over the trailing 12 months.
Which sector does the Xenetic Biosciences company belong to?
The Xenetic Biosciences sector is Healthcare.
Xenetic Biosciences XBIO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25476.64 USD — |
-0.43
|
14.18B USD — | 25354.66 USD — | 25840.56 USD — | — - | 14.18B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
143.63 USD — |
-1.98
|
— — | 142.57 USD — | 146.35 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1203.64 USD — |
+1.6
|
— — | 1192.12 USD — | 1213.64 USD — | — - | — — |
- {{ link.label }} {{link}}